1. Blondeau JM, Hansen G, Metzler K, et al. The role of PK/PD parameters to avoid selection and increase of resistance: mutant prevention concentration. J Chemother 2004; 16 suppl 3: 1-19.
2. Metzler K, Hansen GM, Hedlin P, et al. Comparison of minimal inhibitory and mutant prevention drug concentrations of 4 fluoroquinolones against clinical isolates of methicillin-susceptible and -resistant Staphylococcus aureus. Int J Antimicrob Agents 2004; 24(2): 161-167.
3. Szałek E, Tomczak H, Smuszkiewicz P, et al. Podstawowe wskaźniki PK/PD stosowane w antybiotykoterapii. Anestezjologia i Ratownictwo 2009; 3: 88-93.
4. Scaglione F. Can PK/PD be used in everyday clinical practice? Int J Antimicrob Agents 2002; 19(4): 349-353.
5. Jacobs MR. How can we predict bacterial eradication? Int J Infect Dis 2003; 7 Suppl 1: S13-20.
6. Mouton JW, Dudley MN, Cars O, et al. Standardization of pharmacokinetic/pharmacodynamic (PK/PD) terminology for anti-infective drugs: an update. J Antimicrob Chemother 2005; 55: 601-607.